echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > Mycophenolate sodium enteric-coated tablets, a subsidiary of Hengrui Pharmaceuticals, was approved for listing

    Mycophenolate sodium enteric-coated tablets, a subsidiary of Hengrui Pharmaceuticals, was approved for listing

    • Last Update: 2021-05-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On April 6, Hengrui Medicine issued an announcement stating that its subsidiary Chengdu Shengdi had recently received the "Drug Registration Certificate" for mycophenolate sodium enteric-coated tablets approved and issued by the State Food and Drug Administration.

    Mycophenolate Sodium is a hypoxanthine monophosphate dehydrogenase (IMPDH) inhibitor.
    It is suitable for combination with cyclosporine and corticosteroids to prevent acute rejection in adult patients receiving allogeneic kidney transplantation.

    Mycophenolate sodium enteric-coated tablets were developed by Novartis under the trade name Myfortic.
    They were first approved for listing in Switzerland in October 2002, and are currently on the market in the United States, China, the European Union and other countries and regions.
    At present, except for Novartis, only Chengdu Shengdi's products have been approved for listing.

    Upon inquiry, the global sales of mycophenolic acid tablets in 2019 was approximately US$499.
    68 million.
    Up to now, the total R&D expenditure of the Mycophenolate Sodium Enteric-coated Tablets project is approximately RMB 27.
    96 million.

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.
    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.